HUP9900659A3 - Use of alendronate for prevention of osteoporosis - Google Patents
Use of alendronate for prevention of osteoporosisInfo
- Publication number
- HUP9900659A3 HUP9900659A3 HU9900659A HUP9900659A HUP9900659A3 HU P9900659 A3 HUP9900659 A3 HU P9900659A3 HU 9900659 A HU9900659 A HU 9900659A HU P9900659 A HUP9900659 A HU P9900659A HU P9900659 A3 HUP9900659 A3 HU P9900659A3
- Authority
- HU
- Hungary
- Prior art keywords
- alendronate
- osteoporosis
- prevention
- Prior art date
Links
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 229940062527 alendronate Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45819595A | 1995-06-02 | 1995-06-02 | |
| PCT/US1996/007912 WO1996038156A1 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for the prevention of osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9900659A2 HUP9900659A2 (hu) | 2001-04-28 |
| HUP9900659A3 true HUP9900659A3 (en) | 2002-12-28 |
Family
ID=23819759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900659A HUP9900659A3 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for prevention of osteoporosis |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0828496A1 (bg) |
| JP (1) | JPH10506648A (bg) |
| KR (1) | KR19990022436A (bg) |
| CN (1) | CN1192685A (bg) |
| AU (1) | AU709196B2 (bg) |
| BG (1) | BG63103B1 (bg) |
| BR (1) | BR9609020A (bg) |
| CA (1) | CA2222318A1 (bg) |
| CZ (1) | CZ381197A3 (bg) |
| EA (1) | EA000677B1 (bg) |
| EE (1) | EE03306B1 (bg) |
| HU (1) | HUP9900659A3 (bg) |
| IL (1) | IL118422A0 (bg) |
| IS (1) | IS4617A (bg) |
| NO (1) | NO975527D0 (bg) |
| NZ (1) | NZ308935A (bg) |
| PL (1) | PL323669A1 (bg) |
| SK (1) | SK159597A3 (bg) |
| TR (1) | TR199701482T1 (bg) |
| WO (1) | WO1996038156A1 (bg) |
| ZA (1) | ZA964465B (bg) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
| KR100317935B1 (ko) * | 1999-10-20 | 2001-12-22 | 유승필 | 대사성 골질환 치료용 약제조성물 및 이의 제조방법 |
| JP2004528365A (ja) * | 2001-05-02 | 2004-09-16 | ノバルティス アクチエンゲゼルシャフト | 骨再吸収症および骨粗しょう症の処置または予防におけるビスホスホネートの吸入投与方法 |
| JP2010043119A (ja) * | 2009-10-16 | 2010-02-25 | Gador Sa | 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用 |
| KR102472749B1 (ko) * | 2022-01-18 | 2022-12-02 | 주식회사 위엔씨 | 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366965A (en) * | 1993-01-29 | 1994-11-22 | Boehringer Mannheim Gmbh | Regimen for treatment or prophylaxis of osteoporosis |
| US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
-
1996
- 1996-05-27 IL IL11842296A patent/IL118422A0/xx unknown
- 1996-05-29 CA CA002222318A patent/CA2222318A1/en not_active Abandoned
- 1996-05-29 SK SK1595-97A patent/SK159597A3/sk unknown
- 1996-05-29 KR KR1019970708917A patent/KR19990022436A/ko not_active Application Discontinuation
- 1996-05-29 TR TR97/01482T patent/TR199701482T1/xx unknown
- 1996-05-29 CN CN96196075A patent/CN1192685A/zh active Pending
- 1996-05-29 HU HU9900659A patent/HUP9900659A3/hu unknown
- 1996-05-29 AU AU58824/96A patent/AU709196B2/en not_active Ceased
- 1996-05-29 JP JP8536616A patent/JPH10506648A/ja active Pending
- 1996-05-29 CZ CZ973811A patent/CZ381197A3/cs unknown
- 1996-05-29 BR BR9609020A patent/BR9609020A/pt not_active Application Discontinuation
- 1996-05-29 EE EE9700308A patent/EE03306B1/xx not_active IP Right Cessation
- 1996-05-29 WO PCT/US1996/007912 patent/WO1996038156A1/en not_active Application Discontinuation
- 1996-05-29 EP EP96920553A patent/EP0828496A1/en not_active Withdrawn
- 1996-05-29 PL PL96323669A patent/PL323669A1/xx unknown
- 1996-05-29 EA EA199700449A patent/EA000677B1/ru not_active IP Right Cessation
- 1996-05-29 NZ NZ308935A patent/NZ308935A/en unknown
- 1996-05-31 ZA ZA964465A patent/ZA964465B/xx unknown
-
1997
- 1997-11-19 IS IS4617A patent/IS4617A/is unknown
- 1997-11-20 BG BG102060A patent/BG63103B1/bg unknown
- 1997-12-01 NO NO975527A patent/NO975527D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO975527L (no) | 1997-12-01 |
| EP0828496A1 (en) | 1998-03-18 |
| EE03306B1 (et) | 2000-12-15 |
| EA000677B1 (ru) | 2000-02-28 |
| IL118422A0 (en) | 1996-09-12 |
| BR9609020A (pt) | 1999-07-06 |
| HUP9900659A2 (hu) | 2001-04-28 |
| CN1192685A (zh) | 1998-09-09 |
| ZA964465B (en) | 1996-12-11 |
| AU709196B2 (en) | 1999-08-26 |
| WO1996038156A1 (en) | 1996-12-05 |
| KR19990022436A (ko) | 1999-03-25 |
| SK159597A3 (en) | 1998-06-03 |
| NO975527D0 (no) | 1997-12-01 |
| CZ381197A3 (cs) | 1998-06-17 |
| IS4617A (is) | 1997-11-19 |
| JPH10506648A (ja) | 1998-06-30 |
| NZ308935A (en) | 2000-07-28 |
| AU5882496A (en) | 1996-12-18 |
| TR199701482T1 (xx) | 1998-03-21 |
| EA199700449A1 (ru) | 1998-06-25 |
| BG63103B1 (bg) | 2001-04-30 |
| PL323669A1 (en) | 1998-04-14 |
| BG102060A (bg) | 1998-07-31 |
| CA2222318A1 (en) | 1996-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA988886B (en) | Formulation for treatment of osteoporosis | |
| GB9407135D0 (en) | Treatment of osteoporosis | |
| IL117125A0 (en) | Hydrosilylation of unsaturated compounds | |
| ZA95556B (en) | Combination treatment for osteoporosis | |
| HUT76781A (en) | Mortar for fixing of fixing parts | |
| GB9500691D0 (en) | Compounds | |
| HUP9900659A3 (en) | Use of alendronate for prevention of osteoporosis | |
| GB9621852D0 (en) | Inhibition of scale | |
| HUP9603529A3 (en) | Femoral part of hip-joint-prothesis | |
| EP0837863A4 (en) | DISODIUM ALENDRONATE PREPARATIONS | |
| EP0981545A4 (en) | TREATMENT OF OSTEOPOROSIS | |
| EP0821961A4 (en) | INHIBITOR OF NEOVASCULARIZATION | |
| IL120955A0 (en) | Treatment of osteoporosis | |
| IL117969A0 (en) | Inhibiting photodecomposition of 3-substituted-2-oxinoles | |
| GB9502540D0 (en) | Compounds | |
| GB9603125D0 (en) | Topical bisphosphonates for prevention of bone resorption | |
| IL128109A0 (en) | A therapeutic agent for osteoporosis | |
| ZA968383B (en) | Composition for treatment of osteoporosis. | |
| IL110183A0 (en) | Osteoporosis prevention apparatus | |
| HU800U (en) | Fastening of knee | |
| GB9521509D0 (en) | Inhibition of scale | |
| HU9500013V0 (en) | Construction for prevention of theft | |
| ZA933337B (en) | Novel dosage forms of risedronate | |
| HU9500223D0 (en) | Device for prevention of snoring | |
| SI1175904T1 (sl) | Alendronat za rabo pri zdravljenju osteoporoze |